Document Detail


Effect of DNA repair gene polymorphisms on BPDE-DNA adducts in human lymphocytes.
MedLine Citation:
PMID:  12115580     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
To determine whether variations in DNA repair genes are related to host DNA damage, we investigated the association between polymorphism in the XPD gene (codon 199, 312, 751) and the XRCC1 gene (codon 194, 399) and the presence of benzo(a)pyrene diolepoxide adducts to lymphocyte DNA (BPDE-DNA) in a group of male patients with incident lung cancer, all current smokers. BPDE-DNA adducts were analyzed by high-resolution gas chromatography-negative ion chemical ionization-mass spectrometry. XPD and XRCC1 genotypes were identified by PCR-RFLP. XRCC1 and XPD genotypes did not affect the levels and proportion of detectable BPDE-DNA adducts. The patients were also genotyped for the GSTM1 polymorphism, given its role in the detoxification of BPDE. Individuals with the GSTM1 deletion had significantly higher levels of BPDE-DNA adducts when they were XPD-Asp312Asp+Lys751Lys than carriers of at least one variant allele. No such association was found with the XRCC1 genotypes. Because of the small study population (n = 60), further statistical analysis of possible gene-gene and gene-environment would not be informative. This is the first study analysing the specific BPDE-DNA adduct in vivo with regard to polymorphic repair genes (XPD, XRCC1) and xenobiotic metabolizing gene (GSTM1). Our results raise the possibility that the XPD-Asp312Asp+Lys751Lys genotype may increase BPDE-DNA damage; this effect might be evident in individuals who are especially likely to have accumulated damage, probably because of lower detoxification capacity and high environmental exposure.
Authors:
Roberta Pastorelli; Annalisa Cerri; Maurizio Mezzetti; Erica Consonni; Luisa Airoldi
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of cancer. Journal international du cancer     Volume:  100     ISSN:  0020-7136     ISO Abbreviation:  Int. J. Cancer     Publication Date:  2002 Jul 
Date Detail:
Created Date:  2002-07-12     Completed Date:  2002-07-29     Revised Date:  2007-07-24    
Medline Journal Info:
Nlm Unique ID:  0042124     Medline TA:  Int J Cancer     Country:  United States    
Other Details:
Languages:  eng     Pagination:  9-13     Citation Subset:  IM    
Copyright Information:
Copyright 2002 Wiley-Liss, Inc.
Affiliation:
Laboratory of Molecular Toxicology, Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy. rpastorelli@marionegri.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide / metabolism*
DNA Adducts / metabolism*
DNA Damage*
DNA Helicases*
DNA Repair / genetics*
DNA-Binding Proteins / genetics
Gas Chromatography-Mass Spectrometry
Genotype
Humans
Lung Neoplasms / genetics
Lymphocytes / metabolism*
Middle Aged
Polymerase Chain Reaction
Polymorphism, Genetic*
Polymorphism, Restriction Fragment Length
Proteins / genetics
Smoking
Transcription Factors*
Xeroderma Pigmentosum Group D Protein
Chemical
Reg. No./Substance:
0/DNA Adducts; 0/DNA-Binding Proteins; 0/Proteins; 0/Transcription Factors; 0/X-ray repair cross complementing protein 1; 0/benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide-DNA; 55097-80-8/7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide; EC 3.6.1.-/DNA Helicases; EC 5.99.-/ERCC2 protein, human; EC 5.99.-/Xeroderma Pigmentosum Group D Protein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Peripheral lymph node stromal cells can promote growth and tumorigenicity of breast carcinoma cells ...
Next Document:  Differential production of angiostatin by concomitant antitumoral resistance-inducing cancer cells.